586 cases of congenital CMV infection were reported (~8 per 100,000 births) BUT this is only 1% of the number expected in Australia on the basis of their estimated prevalence in developed countries indicating need for greater surveillance and reporting as infants are not routinely screened for congenital CMV infections
most frequent sequelae of definite infections were:
small for gestational age or intrauterine growth restriction (135 infants, 28.2%);
the ensuing immune response may affect milk composition, neonatal gut flora with lower levels of beneficial flora, and impaired development of gut microbiome and impaired infant growth. 3)